Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-13-060093
Filing Date
2013-02-14
Accepted
2013-02-14 16:09:49
Documents
2
Group Members
VENROCK ASSOCIATES II, L.PVENROCK ENTREPRENEURS FUND, L.PVENROCK HEALTHCARE CAPITAL PARTNERS, L.P.VENROCK MANAGEMENT, LLCVHCP CO-INVESTMENT HOLDINGS, LLCVR MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G d481825dsc13ga.htm SC 13G/A 167043
2 EXHIBIT 99.1 d481825dex991.htm EX-99.1 9408
  Complete submission text file 0001193125-13-060093.txt   178168
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-85292 | Film No.: 13613665
SIC: 2834 Pharmaceutical Preparations